SynopsisThe global Chimeric Antigen Receptor Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD .....
SynopsisTramadol (INN) is a non-opioid central analgesic that can also bind to opioid receptors, but its affinity is weak, with an affinity for the relative receptors equivalent to 1/6000 of morphine, and only 1/25 of the affinity for and receptors.The drug is synthet.....
SynopsisThe global Restriction Enzyme market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Restriction Enzyme is estimated to increase fro.....
SynopsisAs for March, 26 2020: Dr. Eleanor Fish (a prominent immunologist at the University of Toronto, Canada) comments that she does not think BCG may completely eliminate infection caused by a novel coronavirus, but it is likely to mitigate the effect.....
SynopsisThe global Slipper Pan Liners market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Slipper Pan Liners in various end use industries. The expanding demands.....
SynopsisLurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In bipolar it may be used together with a mood stabilizer such as lithium or valproate. It is taken by mouth. The .....
SynopsisOPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer. The global Nivolumab Drugs market was valued at US$ 9567 million in 2023 and is anticipated to reach US$ 15620 million by 2030, witnessing a CAGR of 6.8% during the for.....
SynopsisBiliary stents are small mesh-like tubes, which do not contain any coating or covering. Stents are inserted into the liver to treat hepatic blockage and obstructive hepatic diseases, such as jaundice, cholecystitis, hepato-biliary diseases, and cholangitis. Bi.....
SynopsisThe global Vascular Embolization Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devic.....
SynopsisThe global Gastrointestinal (GI) Stents market size is expected to reach US$ 590.9 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Gastrointestinal (GI) Stents in various end use indu.....
